Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lindsey S Jung"'
Autor:
Anne Hwang, Christopher Shi, Edward Zhu, Farha Naaz, Ping Zhou, Zainab Rasheed, Michelle Liu, Lindsey S Jung, Bin Duan, Jingsong Li, Kai Jiang, Latha Paka, Satishkumar V Gadhiya, Dibyendu Dana, Quaisar Ali, Michael A Yamin, Itzhak D Goldberg, Prakash Narayan
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198937 (2018)
Although cirrhosis is a key risk factor for the development of hepatocellular carcinoma (HCC), mounting evidence indicates that in a subset of patients presenting with non-alcoholic steatohepatitis (NASH) HCC manifests in the absence of cirrhosis. Gi
Externí odkaz:
https://doaj.org/article/1518570945cf4c56b70a89b77545c7f9
Publikováno v:
The Protein Journal
Remdesivir was approved by the U.S.A. Food and Drug administration for emergency use to interfere with the replication of SARS CoV-2 virus (the agent that causes COVID-19) in adults and children hospitalized with severe disease. The crystal structure
Autor:
David D McManus, Ludovic Trinquart, Emelia J Benjamin, Emily S Manders, Kelsey Fusco, Lindsey S Jung, Nicole L Spartano, Vik Kheterpal, Christopher Nowak, Mayank Sardana, Joanne M Murabito
BACKGROUND New models of scalable population-based data collection that integrate digital and mobile health (mHealth) data are necessary. OBJECTIVE The aim of this study was to describe a cardiovascular digital and mHealth electronic cohort (e-cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d65adac0e41d6b4ae664596ca1d1fbc
https://doi.org/10.2196/preprints.12143
https://doi.org/10.2196/preprints.12143
Autor:
Michael A. Yamin, Ping Zhou, Christopher Shi, Bin Duan, Satishkumar Gadhiya, Farha Naaz, Dibyendu Dana, Prakash Narayan, Zainab Rasheed, Kai Jiang, Latha Paka, Lindsey S. Jung, Jingsong Li, Edward Zhu, Michelle Liu, Itzhak D. Goldberg, Anne Hwang, Quaisar Ali
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 6, p e0198937 (2018)
PLoS ONE, Vol 13, Iss 6, p e0198937 (2018)
Although cirrhosis is a key risk factor for the development of hepatocellular carcinoma (HCC), mounting evidence indicates that in a subset of patients presenting with non-alcoholic steatohepatitis (NASH) HCC manifests in the absence of cirrhosis. Gi